Inhalation Meds

Featured Article

Drugmaker MAP Pharmaceuticals says that their inhaled migraine medication Levadex met all four of the study's goals in a recent clinical trial. The drug, formerly called MAP0004, was better than a placebo at controlling symptoms of pain, nausea, and sensitivity to light. Researchers also say the study on 792 patients found that Levadex reduced pain in half an hour, and sustained pain relief for 48 hours without showing any serious adverse effects. Levadex is an inhaled version of an older...

Read more

More information on "Inhalation Meds"

From Our Experts

See more SharePosts »

From Our Sources

More on Asthma »